Table 4.

Survival of patients with CML with (Group A) or without (Group B) a previous documented history of peptic ulcer, gastritis, or dyspepsia, or use of PPIs.

Unadjusted dataAge adjusted data
n1-Year survival5-Year survivalHR (95% CI)HR (95% CI)
Group A16989781.2 (0.9–1.8)0.8 (0.6–1.2)
 Peptic ulcer3171592.4 (1.4–4.2)1.9 (1.1–3.3)
 Gastritis3491641.7 (0.9–3.2)1.3 (0.7–2.4)
 Dyspepsia2090900.8 (0.3–2.5)0.5 (0.2–1.5)
 PPI13392811.0 (0.7–1.6)0.7 (0.4–1.1)
Group B81194801 (ref; —)1 (ref; —)